Literature DB >> 11895870

The influence of folate and multivitamin use on the familial risk of colon cancer in women.

Charles S Fuchs1, Walter C Willett, Graham A Colditz, David J Hunter, Meir J Stampfer, Frank E Speizer, Edward L Giovannucci.   

Abstract

Low intake of folate and methionine and heavy alcohol consumption have been associated with an increased overall risk of colon cancer, possibly related to their role in methylation pathways. We estimated the relative risk (RR) of colon cancer according to a history of colorectal cancer in a first-degree relative and categories of folate, methionine, and alcohol intake in a prospective cohort study of 88,758 women who completed family history and detailed food frequency questionnaires. During 16 years of follow-up, colon cancer was diagnosed in 535 women. The inverse association of folic acid with colon cancer risk was greater in women with a family history. Compared with women who consumed 200 microg or less of folic acid/day, the age-adjusted RR of colon cancer for those who consumed >400 microg/day was 0.81 (95% confidence interval, 0.62-1.07) in women without a family history of colorectal cancer and 0.48 (95% confidence interval, 0.28-0.83) in women with a family history (P for interaction = 0.02). The influence of family history was markedly diminished by use of multivitamins containing folic acid (P for interaction = 0.04). High levels of dietary methionine also reduced the effect of family history (P for interaction = 0.05), whereas moderate to heavy alcohol consumption increased the risk associated with family history (P for interaction = 0.004). Other risk factors for colorectal cancer did not significantly modify the influence of family history. Our results suggest that higher intake of folate and methionine, regular use of multivitamins containing folate, and avoidance of moderate to heavy alcohol consumption may diminish the excess risk of colon cancer associated with a family history of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895870

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  35 in total

1.  Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States.

Authors:  Todd M Gibson; Stephanie J Weinstein; Ruth M Pfeiffer; Albert R Hollenbeck; Amy F Subar; Arthur Schatzkin; Susan T Mayne; Rachael Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2011-08-03       Impact factor: 7.045

2.  Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.

Authors:  Marian L Neuhouser; Ting-Yuan David Cheng; Shirley A A Beresford; Elissa Brown; Xiaoling Song; Joshua W Miller; Yingye Zheng; Cynthia A Thomson; James M Shikany; Mara Z Vitolins; Thomas Rohan; Ralph Green; Cornelia M Ulrich
Journal:  Int J Cancer       Date:  2015-02-24       Impact factor: 7.396

3.  Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Mami Cantor; Gregory J Kirkner; Donna Spiegelman; G Mike Makrigiorgos; Daniel J Weisenberger; Peter W Laird; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

4.  Alcohol consumption and the risk of colon cancer by family history of colorectal cancer.

Authors:  Eunyoung Cho; Jung Eun Lee; Eric B Rimm; Charles S Fuchs; Edward L Giovannucci
Journal:  Am J Clin Nutr       Date:  2012-01-04       Impact factor: 7.045

5.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

6.  Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer.

Authors:  Maureen A Murtaugh; Karen Curtin; Carol Sweeney; Roger K Wolff; Richard Holubkov; Bette J Caan; Martha L Slattery
Journal:  Cancer Causes Control       Date:  2007-01-23       Impact factor: 2.506

7.  Vitamin and multiple-vitamin supplement intake and incidence of colorectal cancer: a meta-analysis of cohort studies.

Authors:  Yan Liu; Qiuyan Yu; Zhenli Zhu; Jun Zhang; Meilan Chen; Pingyi Tang; Ke Li
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

8.  Folate production by bifidobacteria as a potential probiotic property.

Authors:  Anna Pompei; Lisa Cordisco; Alberto Amaretti; Simona Zanoni; Diego Matteuzzi; Maddalena Rossi
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

9.  Chemoprevention for colorectal neoplasia.

Authors:  Alyssa D Fajardo; Bruce W Robb
Journal:  Clin Colon Rectal Surg       Date:  2008-11

10.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Authors:  Rowena Chau; Seyedeh Ghazaleh Dashti; Driss Ait Ouakrim; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Joanne P Young; Graham G Giles; Finlay A Macrae; Alex Boussioutas; Susan Parry; Jane C Figueiredo; A Joan Levine; Dennis J Ahnen; Graham Casey; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Stephen N Thibodeau; Noralane M Lindor; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  Int J Epidemiol       Date:  2016-04-10       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.